Related references
Note: Only part of the references are listed.Redefinition of the human mast cell transcriptome by deep-CAGE sequencing
Efthymios Motakis et al.
BLOOD (2014)
IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation
Felice Rivellese et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut
Susanne Sattler et al.
JOURNAL OF AUTOIMMUNITY (2014)
Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis
Albert Dahdah et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Intravenous Immunoglobulin Treatment in Humans Suppresses Dendritic Cell Function via Stimulation of IL-4 and IL-13 Production
Angela S. W. Tjon et al.
JOURNAL OF IMMUNOLOGY (2014)
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Chris Schiering et al.
NATURE (2014)
New learnings on the pathophysiology of RA from synovial biopsies
Costantino Pitzalis et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Communication between human mast cells and CD4+ T cells through antigen-dependent interactions
Jolien Suurmond et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Innate Immunity and Its Regulation by Mast Cells
Ashley L. St John et al.
JOURNAL OF IMMUNOLOGY (2013)
Protective and pathological roles of mast cells and basophils
David Voehringer
NATURE REVIEWS IMMUNOLOGY (2013)
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Dominique Talabot-Ayer et al.
JOINT BONE SPINE (2012)
Interleukin-33 Primes Mast Cells for Activation by IgG Immune Complexes
Shinjiro Kaieda et al.
PLOS ONE (2012)
New models for analyzing mast cell functions in vivo
Laurent L. Reber et al.
TRENDS IN IMMUNOLOGY (2012)
Mast cells are important modifiers of autoimmune disease: with so much evidence, why is there still controversy?
Melissa A. Brown et al.
FRONTIERS IN IMMUNOLOGY (2012)
Collagen-induced arthritis is not impaired in mast cell-deficient mice
Nick Pitman et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
IL-33: a promising therapeutic target for rheumatoid arthritis?
Feng-Lai Yuan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated Autoimmunity
Thorsten B. Feyerabend et al.
IMMUNITY (2011)
IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α-Mediated Bone Loss
Mario M. Zaiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Robert M. Anthony et al.
NATURE (2011)
Mast Cell-Derived Tryptase Inhibits Apoptosis of Human Rheumatoid Synovial Fibroblasts via Rho-Mediated Signaling
Norifumi Sawamukai et al.
ARTHRITIS AND RHEUMATISM (2010)
Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells
Sonia Merluzzi et al.
BLOOD (2010)
IL-33 Exacerbates Autoantibody-Induced Arthritis
Damo Xu et al.
JOURNAL OF IMMUNOLOGY (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Tyrosine kinases as targets for the treatment of rheumatoid arthritis
Christina D'Aura Swanson et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
Jacques Tebib et al.
ARTHRITIS RESEARCH & THERAPY (2009)
The role of Toll-like receptors in rheumatoid arthritis
Qi-Quan Huang et al.
Current Rheumatology Reports (2009)
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Damo Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
Stephen J. Galli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
David Moulin et al.
CYTOKINE (2007)
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells
Zouna Allakhverdi et al.
JOURNAL OF IMMUNOLOGY (2007)
Monoclonal antibodies capable of discriminating the human inhibitory Fcγ-receptor IIB (CD32B) from the activating Fcγ-receptor IIA (CD32A):: biochemical, biological and functional characterization
Maria-Concetta Veri et al.
IMMUNOLOGY (2007)
Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-α, IL-1β and IL-1Ra
C. Sandler et al.
INFLAMMATION RESEARCH (2007)
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
Peter A. Nigrovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
AM Boruchov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia:: a potential approach to the treatment of arthritis
A Juurikivi et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases
KK Eklund et al.
ANNALS OF MEDICINE (2003)
Mast cells: A cellular link between autoantibodies and inflammatory arthritis
DM Lee et al.
SCIENCE (2002)
Share Paper
